Deborah Crouch

Array ( [id] => 7625277 [patent_doc_number] => 06723893 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-20 [patent_title] => 'Mice having a mutant SOD-1-encoding transgene' [patent_app_type] => B1 [patent_app_number] => 08/204052 [patent_app_country] => US [patent_app_date] => 1994-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 21188 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723893.pdf [firstpage_image] =>[orig_patent_app_number] => 08204052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359071 [patent_doc_number] => 06218596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Enhancement of musculature in non-human mammals expressing c-ski' [patent_app_type] => 1 [patent_app_number] => 8/202841 [patent_app_country] => US [patent_app_date] => 1994-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 29 [patent_no_of_words] => 9713 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218596.pdf [firstpage_image] =>[orig_patent_app_number] => 202841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619214 [patent_doc_number] => 05614396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Methods for the genetic modification of endogenous genes in animal cells by homologous recombination' [patent_app_type] => 1 [patent_app_number] => 8/200011 [patent_app_country] => US [patent_app_date] => 1994-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 28 [patent_no_of_words] => 19538 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614396.pdf [firstpage_image] =>[orig_patent_app_number] => 200011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636003 [patent_doc_number] => 05610288 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Antisense polynucleotide inhibition of epidermal human growth factor receptor expression' [patent_app_type] => 1 [patent_app_number] => 8/200924 [patent_app_country] => US [patent_app_date] => 1994-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11954 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610288.pdf [firstpage_image] =>[orig_patent_app_number] => 200924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626139 [patent_doc_number] => 05602304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Hairless mouse' [patent_app_type] => 1 [patent_app_number] => 8/197619 [patent_app_country] => US [patent_app_date] => 1994-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5537 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602304.pdf [firstpage_image] =>[orig_patent_app_number] => 197619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4078301 [patent_doc_number] => 05965788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Transgenic non-human mammal comprising a rabbit WAP promoter' [patent_app_type] => 1 [patent_app_number] => 8/162146 [patent_app_country] => US [patent_app_date] => 1994-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5456 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965788.pdf [firstpage_image] =>[orig_patent_app_number] => 162146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1261286 [patent_doc_number] => 06664107 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'CD45 disrupted nucleic acid' [patent_app_type] => B1 [patent_app_number] => 08/191225 [patent_app_country] => US [patent_app_date] => 1994-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 16165 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/664/06664107.pdf [firstpage_image] =>[orig_patent_app_number] => 08191225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728032 [patent_doc_number] => 05703055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Generation of antibodies through lipid mediated DNA delivery' [patent_app_type] => 1 [patent_app_number] => 8/187630 [patent_app_country] => US [patent_app_date] => 1994-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23179 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/703/05703055.pdf [firstpage_image] =>[orig_patent_app_number] => 187630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4036070 [patent_doc_number] => 05994616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Targeted synthesis of protein in mammary gland of a non-human transgenic mammal' [patent_app_type] => 1 [patent_app_number] => 8/186836 [patent_app_country] => US [patent_app_date] => 1994-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 7950 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994616.pdf [firstpage_image] =>[orig_patent_app_number] => 186836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661769 [patent_doc_number] => 05624912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Method of treating HIV infection and related secondary infections with defibrotide' [patent_app_type] => 1 [patent_app_number] => 8/185416 [patent_app_country] => US [patent_app_date] => 1994-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 17998 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624912.pdf [firstpage_image] =>[orig_patent_app_number] => 185416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3493076 [patent_doc_number] => 05508188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-16 [patent_title] => 'Method of growing cells in a mammal' [patent_app_type] => 1 [patent_app_number] => 8/184720 [patent_app_country] => US [patent_app_date] => 1994-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7985 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/508/05508188.pdf [firstpage_image] =>[orig_patent_app_number] => 184720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883369 [patent_doc_number] => 05833975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence' [patent_app_type] => 1 [patent_app_number] => 8/184009 [patent_app_country] => US [patent_app_date] => 1994-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 46 [patent_no_of_words] => 63736 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/833/05833975.pdf [firstpage_image] =>[orig_patent_app_number] => 184009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3694103 [patent_doc_number] => 05618709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein' [patent_app_type] => 1 [patent_app_number] => 8/183211 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 14264 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618709.pdf [firstpage_image] =>[orig_patent_app_number] => 183211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636999 [patent_doc_number] => 05631407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Transgenic mouse expressing DNA sequences encoding the human poliovirus receptor' [patent_app_type] => 1 [patent_app_number] => 8/182371 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 12630 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631407.pdf [firstpage_image] =>[orig_patent_app_number] => 182371 [rel_patent_id] =>[rel_patent_doc_number] =>)